Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Washington A. Eugene

(Last) (First) (Middle)


(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Share Units (1) 12/11/2018 A 307.438 (1) (1) Common Stock 307.438 $0.0000 17,600.9823 D
Explanation of Responses:
1. The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).
Maria A. Frucci, as attorney-in-fact for A. Eugene Washington 12/13/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
	Know all persons by these presents, that the undersigned hereby constitutes and
  appoints each of Thomas J. Spellman III, Renee A. Brutus, Michelle R. Ryan, 
Linda E. King and Maria A. Frucci, signing singly, as the undersigned's true and
  lawful attorneys-in-fact to:

(1)	complete and execute for and on behalf of the undersigned, in the 
undersigned's capacity as a director of Johnson & Johnson (the "Company"), Forms
  3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a)
  of the Securities Exchange Act of 1934, as amended, and the rules and 
regulations promulgated thereunder (the "Exchange Act") and Form 144 in 
accordance with Rule 144 of the Securities Act of 1933, as amended, and the 
rules and regulations promulgated thereunder (the "Securities Act");

(2)	do and perform any and all acts for and on behalf of the undersigned which 
may be necessary or desirable to complete and execute any such Form 3, 4, 5 and 
144 (including any amendments thereto) and timely file such form with the United
  States Securities and Exchange Commission and any stock exchange or similar 
authority; and 

(3)	take any other action of any type whatsoever in connection with the 
foregoing which, in the opinion of such attorney-in-fact,
 may be of benefit to, 
in the best interest of, or legally required by, the undersigned, it being 
understood that the documents executed by such attorney-in-fact on behalf of the
  undersigned pursuant to this Power of Attorney shall be in such form and shall
  contain such terms and conditions as such attorney-in-fact may approve in such
  attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power and 
authority to do and perform any and every act and thing whatsoever requisite, 
necessary, or proper to be done in the exercise of any of the rights and powers 
herein granted, as fully to all intents and purposes as the undersigned might or
  could do if personally present, with full power of substitution or revocation,
  hereby ratifying and confirming all that such attorney-in-fact, or such 
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be 
done by virtue of this power of attorney and the rights and powers herein 
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in 
serving in such capacity at the request of the undersigned, are not assuming, 
nor is the Company assuming, (i) any of the undersigned's responsibilities to 
comply with Section 16 of the Exchange Act or Rule 144 of the Securities Act or 
(ii) any liability of the undersigned for failure to comply with such 
requirements. The undersigned agrees that each such attorney-in-fact may rely 
entirely on information furnished orally or in writing by or at the direction of
  the undersigned to the attorney-in-fact. 

	This Power of Attorney shall remain in full force and effect until the 
undersigned is no longer required to file Forms 3, 4, 5 and 144 with respect to 
the undersigned's holdings of and transactions in securities issued by the 
Company, unless earlier revoked by the undersigned in a signed writing delivered
  to the foregoing attorneys-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be 
executed as of the date set forth below.

	       /s/  A. Eugene Washinton
	Name:  A. Eugene Washington
	Date:  October 18, 2018